Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00397930 · ClinicalTrials.gov registry record · Phase 2
Yoga in Treating Sleep Disturbance in Cancer Survivors
A Phase 2 study of Cancer and Fatigue, sponsored by Gary Morrow.
- Completed
- Registry status
- Phase 2
- Development phase
- 410
- Enrollment target
- 11
- Study locations
NCT00397930: Completed Phase 2 study of Cancer and Fatigue, sponsored by Gary Morrow.
NCT00397930 is a Phase 2 study of Cancer and Fatigue that has completed, run by Gary Morrow. The registered enrollment target is 410 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00397930, a Phase 2 study of Cancer and Fatigue, has completed, sponsored by Gary Morrow.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 410 participants
- Enrollment target
- 11
- Study locations
Study Summary
RATIONALE: Yoga may help improve sleep, fatigue, and quality of life in cancer survivors. PURPOSE: This phase II trial is studying how well yoga works in treating sleep disturbance in cancer survivors.
Primary Outcome
Pittsburgh Sleep Quality Index: Measures sleep disturbance and usual sleep habits during the prior month only using seven clinically derived domains of sleep difficulties: sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. Global PSQI is a summary of the seven domains. Each Domain is scored from 0 to 3, therefore PSQI has a range of 0 (better) to 21 (worse). Interpretation of the PSQI is that a score
Conditions Studied
Interventions
- PROCEDURE Standard Care Control Condition
- PROCEDURE Yoga Intervention (YOCAS)
Study Locations (11)
Michigan
- CCOP - Grand Rapids - Grand Rapids
- CCOP - Kalamazoo - Kalamazoo
Illinois
- CCOP - Central Illinois - Decatur
Kansas
- CCOP - Wichita - Wichita
Missouri
- CCOP - Kansas City - Kansas City
New York
- CCOP - Hematology-Oncology Associates of Central New York - East Syracuse
North Carolina
- CCOP - Southeast Cancer Control Consortium - Goldsboro
Ohio
- CCOP - Columbus - Columbus
Oregon
- CCOP - Columbia River Oncology Program - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2006-10 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
What the finished NCT00397930 record still lists
NCT00397930 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard Care Control Condition is the first listed.
NCT00397930 lists 11 locations in 10 states (Michigan, Illinois, Kansas).
Frequently Asked Questions
What is clinical trial NCT00397930 about?
NCT00397930 is a clinical study titled "Yoga in Treating Sleep Disturbance in Cancer Survivors". RATIONALE: Yoga may help improve sleep, fatigue, and quality of life in cancer survivors. PURPOSE: This phase II trial is studying how well yoga works in treating sleep disturbance in cancer survivors.
What is the current status of trial NCT00397930?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 410 participants. The study started on 2006-10. Estimated completion is 2013-06.
What conditions does trial NCT00397930 study?
This clinical trial studies the following conditions: Cancer, Fatigue, Sleep Disorders.
What interventions are being tested in trial NCT00397930?
The interventions under investigation include: Standard Care Control Condition (PROCEDURE), Yoga Intervention (YOCAS) (PROCEDURE).
Who is sponsoring clinical trial NCT00397930?
This trial is sponsored by Gary Morrow, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00397930 being conducted?
This trial has 11 study locations across Illinois, Kansas, Michigan, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00397930's enrollment target sits among peer trials
410 146th of 615 higher than 470 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
RECRUITING · Phase 2
-
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
RECRUITING · Phase 2
-
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
RECRUITING · Phase 2
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia